BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 1936997)

  • 1. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
    Wu F; Garcia J; Sigman D; Gaynor R
    Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
    García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
    J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin.
    Sheline CT; Milocco LH; Jones KA
    Genes Dev; 1991 Dec; 5(12B):2508-20. PubMed ID: 1752441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA.
    Hart CE; Saltrelli MJ; Galphin JC; Schochetman G
    J Virol; 1995 Oct; 69(10):6593-9. PubMed ID: 7666565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat.
    Wu-Baer F; Sigman D; Gaynor RB
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7153-7. PubMed ID: 7638159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication.
    Harrich D; Mavankal G; Mette-Snider A; Gaynor RB
    J Virol; 1995 Aug; 69(8):4906-13. PubMed ID: 7609059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and characterization of a TAR-binding nuclear factor from T cells.
    Reddy TR; Suhasini M; Rappaport J; Looney DJ; Kraus G; Wong-Staal F
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):663-9. PubMed ID: 7576925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNA.
    Wu-Baer F; Lane WS; Gaynor RB
    EMBO J; 1995 Dec; 14(23):5995-6009. PubMed ID: 8846792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region.
    Churcher MJ; Lamont C; Hamy F; Dingwall C; Green SM; Lowe AD; Butler JG; Gait MJ; Karn J
    J Mol Biol; 1993 Mar; 230(1):90-110. PubMed ID: 8450553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR.
    Luo Y; Peterlin BM
    J Virol; 1993 Jun; 67(6):3441-5. PubMed ID: 8497060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs.
    Ou SH; Wu F; Harrich D; García-Martínez LF; Gaynor RB
    J Virol; 1995 Jun; 69(6):3584-96. PubMed ID: 7745706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 TAR RNA-binding proteins control TAT activation of translation in Xenopus oocytes.
    Braddock M; Powell R; Blanchard AD; Kingsman AJ; Kingsman SM
    FASEB J; 1993 Jan; 7(1):214-22. PubMed ID: 8422967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA.
    Long KS; Crothers DM
    Biochemistry; 1995 Jul; 34(27):8885-95. PubMed ID: 7612630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA.
    Delling U; Roy S; Sumner-Smith M; Barnett R; Reid L; Rosen CA; Sonenberg N
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6234-8. PubMed ID: 2068104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors.
    Gatignol A; Duarte M; Daviet L; Chang YN; Jeang KT
    Gene Expr; 1996; 5(4-5):217-28. PubMed ID: 8723388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
    Tao J; Frankel AD
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1571-5. PubMed ID: 8434019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.
    Luo Y; Madore SJ; Parslow TG; Cullen BR; Peterlin BM
    J Virol; 1993 Sep; 67(9):5617-22. PubMed ID: 8350414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.